• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Athernal Bio

To add a bio or update company history, please click update information.

News from Athernal Bio

    Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditionsAthernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions
    Athernal Bio
    2 Oct 2025

    Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

    Athernal Bio is developing immunotherapies for clonal haematopoiesis, aiming to stop blood cancers before they develop in high-risk patients.

Athernal Bio
  • Life Sciences
  • Cambridge, United Kingdom
  • £3.5m
  • athernalbio.com
  • Update Information

More venture news

  • Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
    Semarion
    31 Mar 2026

    Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery

    EquityLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn